TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 121 filers reported holding TCR2 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,184,869 | +50.0% | 789,911 | -0.1% | 0.00% | – |
| Q4 2022 | $789,924 | -57.2% | 790,873 | -22.9% | 0.00% | – |
| Q3 2022 | $1,847,000 | -38.6% | 1,025,712 | -1.2% | 0.00% | – |
| Q2 2022 | $3,009,000 | -57.0% | 1,037,694 | -59.0% | 0.00% | – |
| Q1 2022 | $6,991,000 | -37.5% | 2,532,916 | +5.5% | 0.00% | – |
| Q4 2021 | $11,193,000 | -55.6% | 2,401,745 | -19.0% | 0.00% | -100.0% |
| Q3 2021 | $25,230,000 | -47.7% | 2,964,645 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $48,197,000 | -28.8% | 2,937,118 | -4.2% | 0.00% | -50.0% |
| Q1 2021 | $67,711,000 | -15.9% | 3,066,636 | +17.8% | 0.00% | -33.3% |
| Q4 2020 | $80,526,000 | +88.1% | 2,603,539 | +23.6% | 0.00% | +50.0% |
| Q3 2020 | $42,806,000 | +154.7% | 2,106,589 | +92.6% | 0.00% | +100.0% |
| Q2 2020 | $16,804,000 | +142.9% | 1,094,017 | +22.4% | 0.00% | – |
| Q1 2020 | $6,919,000 | -45.6% | 893,928 | +0.4% | 0.00% | – |
| Q4 2019 | $12,711,000 | +1.9% | 890,040 | +7.3% | 0.00% | -100.0% |
| Q3 2019 | $12,473,000 | +725.5% | 829,819 | +685.9% | 0.00% | – |
| Q2 2019 | $1,511,000 | – | 105,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |